ArticleJournal of cancer prevention2023

Effectiveness and Safety of Apatinib Plus Programmed Cell Death Protein 1 Blockades for Patients with Treatment-refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study.

Shenglong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.